Earnings Report Digest

Trending stocks, Feb 10 2025

Trending stocks, Feb 7 2025

$NET has released its Q4 2024 earnings, showcasing a strong finish with revenue of $459.9 million, up 27% YoY. Key highlights include an operating profit increase of 69% YoY and a gross margin of 77.6%. However, concerns about customer budget scrutiny persist. 📈

$HLT has released its fourth quarter 2024 earnings, showing solid growth with system-wide RevPAR up 3.5% YoY. Key highlights include adjusted EBITDA of $858M (+7%), and a record net unit growth of 7.3% over the year, indicating strong profitability and financial health. Future growth opportunities are evident with an expected 2-3% RevPAR increase for 2025. Risks include potential softness in China's market, but robust U.S. demand remains promising. 📈🌍 Check details in valueverge.com/HLT.

$APD has released its fourth-quarter earnings, reporting an adjusted EPS of $3.56, a 13% increase from the previous year, and an adjusted EBITDA margin improvement of 460 bp. Notably, Air Products has completed the $1.8 billion sale of its LNG business to Honeywell. 📈

$FTNT has released its fourth quarter earnings, showing strong performance with a record operating margin of 39% and total revenue growth of 17%. However, the billings guidance for Q1 is cautious due to supply chain uncertainties.

$ICE has released its fourth quarter earnings, showcasing a record performance. Key highlights include adjusted EPS of $1.52 (up 14% YoY) and net revenues of $2.3 billion, reflecting a 5% increase. Despite strong total revenues, potential risks such as market volatility and regulatory changes linger.

$BMY posts its earnings report demonstrating solid execution amidst ongoing challenges. Key highlights include a revenue growth of 9% in Q4 and a focus on operational excellence, with an expected 2025 revenue of ~$45.5 billion. Risks include significant LOEs impacting the legacy portfolio, particularly for Revlimid. Noteworthy projections for non-GAAP EPS are between $6.55 to $6.85. Future growth may hinge on new therapies like Cobinfi and strengthened market positions. 🧬📈 Check details at valueverge.com/BMY.

$COP has released its fourth-quarter 2024 earnings, showcasing solid operational execution. The company reported adjusted earnings of $1.98 per share and generated over $5.4 billion in cash flow. Notable highlights include a 4% year-over-year production growth, bolstered by the recent Marathon acquisition, and a strong capital return strategy targeting $10 billion in shareholder distributions.

$HON just released its Q4 2024 earnings report, highlighting strong performance despite ongoing macroeconomic challenges. The company met or exceeded guidance for organic and adjusted earnings growth. Key stats: Organic sales up 3% for the full year, with a notable backlog of $35.3B and segment margins under pressure due to recent acquisitions and product mix. Looking forward, Honeywell is navigating geopolitical uncertainties and planning a strategic separation of its Automation and Aerospace sectors by 2026. 🚀⚠️ For detailed insights: valueverge.com/HON.